Illumina raised the curtain on a revamp of its flagship tumor profiling test, which aims to offer faster turnarounds, fewer materials and fuller coverage of difficult genomic regions with the goal ...

(NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced updates to its agreement with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will release TruSight™ Oncology 500 v2 (TSO 500 v2), a new version of its ...

Illumina is the leader in the undisputed Next Generation Sequencing market. Grail divestment is behind, enabling a margin expansion and fueling a more robust cash flow generation. The stock was ...

Shares of Illumina (NASDAQ:ILMN) fell 6% post-market Monday after the company lowered its fiscal 2024 revenue guidance. The DNA sequencing company reported Q3 adjusted EPS of $1.14, which beat the ...

Based at Lord's Ground in London, we are a cricket charity delivering projects across the UK and around the world. We provide free coaching and match play in order to empower all boys and girls to ...

Since 1973, Puritan’s Pride has produced more than 1,200 vitamins and supplements targeted for a variety of health and wellness needs. Puritan’s Pride states its mission is to provide the ...

The LGBTQ+ community is concerned about RFK Jr.'s Cabinet position ...